The Current Ratio as of June 2025 (TTM) for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) is 4.55

According to Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 4.55. This represents a change of 35.15% compared to the average of 3.37 of the last 4 quarters.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Historical Current Ratio (quarterly & annually)

How has 603707.SS Current Ratio performed in the past?

The mean historical Current Ratio of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd over the last ten years is 3.44. The current 4.55 Current Ratio has changed 13.14% with respect to the historical average. Over the past ten years (40 quarters), 603707.SS's Current Ratio was at its highest in in the March 2017 quarter at 6.83. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Average Current Ratio

How has 603707.SS Current Ratio performed in the past?

The current Current Ratio of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Current Ratio vs. Peers

How is 603707.SS’s Current Ratio compared to its peers?

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd’s Current Ratio is greater than Juewei Food Co., Ltd. (1.26), greater than Guangzhou Kingmed Diagnostics Group Co., Ltd. (3.18), greater than Zhejiang Huahai Pharmaceutical Co., Ltd. (1.62), greater than Jiangsu King's Luck Brewery Joint-Stock Co., Ltd. (1.90), greater than Autobio Diagnostics Co., Ltd. (2.62),

Build a custom stock screener for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.